BioSkaner – Modern Diagnostic Center

BioSkaner – Modern Diagnostic Center for Oncology and Neurology in Poland

BioSkaner is a cutting-edge medical center in Poland specializing in high-precision diagnostics for oncology, neurology, and cardiology.

The clinic utilizes the latest imaging methods, including PET/MR and PET/CT, enabling early detection of pathological processes and precise differential diagnostics.

Advanced Equipment at BioSkaner

The clinic is equipped with state-of-the-art diagnostic systems that combine Positron Emission Tomography (PET) with Magnetic Resonance Imaging (MRI) or Computed Tomography (CT), providing detailed anatomical and functional information about the patient's body.

PET/MR – an advanced technology offering high soft tissue contrast, crucial for detecting oncological and neurological pathologies.

PET/CT – a technology that integrates functional diagnostics with anatomical structure analysis, enabling high-accuracy cancer detection and staging.

Contrast Agents and Radiopharmaceuticals

BioSkaner employs innovative contrast agents and radioactive markers for detailed imaging and functional assessment of organs.

PET/MR:

18F-FDG (Fluorodeoxyglucose) – used for detecting metabolic activity of tumors.
18F-Choline – applied in prostate cancer diagnostics.
68Ga-PSMA – a specific marker for prostate cancer detection.
68Ga-DOTA TATE and 68Ga-DOTA TOC – for neuroendocrine tumor diagnostics.

PET/CT:

68Ga-PSMA, 68Ga-DOTA TATE, 68Ga-DOTA TOC – radiopharmaceuticals for oncology diagnostics.
18F-FDG – a marker for detecting high-metabolic tumors.
18F-Choline – used in prostate and other oncological diagnostics.

Advantages of PET-MRI over PET-CT

One of the key features of BioSkaner is the use of PET-MRI, which has several important advantages over traditional PET-CT:

Absence of ionizing radiation of CT, which makes the method safer for repeated examinations.
High contrast of soft tissues, which allows for better visualization of tumors, especially in the brain and pelvic organs.
Reduction of radiation exposure, which is important for patients who require regular monitoring.
Better differentiation of tumor and inflammatory processes, which contributes to more accurate treatment planning.

Applications of PET-MRI and PET-CT in BioSkaner

Thanks to innovative technologies, the clinic diagnoses the following diseases:

Oncology: lung cancer, breast cancer, prostate cancer, gastrointestinal tract cancer, neuroendocrine tumors.

Neurology: early diagnosis of Alzheimer's disease, Parkinson's disease, epilepsy.

Cardiology: assessment of myocardial viability, diagnosis of inflammatory diseases of the heart muscle.

Why Choose BioSkaner?

State-of-the-art imaging technologies for early disease detection.
Precise diagnostics with innovative contrast agents and radiopharmaceuticals.
Reduced radiation exposure due to PET/MR technology.
Highly qualified specialists ensuring accurate result interpretation.